CompletedPhase 2NCT03758924
Study of ANAVEX2-73 in Patients With Rett Syndrome
Studying Rett syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Anavex Life Sciences Corp.
- Principal Investigator
- Walter Kaufmann, MD, MDEmory University SOM
- Intervention
- ANAVEX2-73(drug)
- Enrollment
- 31 enrolled
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2019 – 2020
Study locations (8)
- UAB | The University of Alabama at Birmingham, Birmingham, Alabama, United States
- UC Davis University of California - Davis MIND Institute, Sacramento, California, United States
- Rush University Medical Center, Chicago, Illinois, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Washington University in St. Louis | Saint Louis Children's Hospital, St Louis, Missouri, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Greenwood Genetic Center, Greenwood, South Carolina, United States
- Baylor College of Medicine, Houston, Texas, United States
Collaborators
International Rett Syndrome Foundation Rettsyndrome.org
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03758924 on ClinicalTrials.govOther trials for Rett syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06840496To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett SyndromeBiomed Industries, Inc.
- RECRUITINGPHASE2NCT07430046Repurposing Mirtazapine in Rett SyndromeUniversity of Trieste
- RECRUITINGNCT06338267Validating Innovative Biosensors for Rett Autonomic Symptom TrackingRett Syndrome Research Trust
- RECRUITINGEARLY PHASE1NCT06856759Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett SyndromeGuangzhou Women and Children's Medical Center
- RECRUITINGNCT06705816Cognitive Function in Rett Syndrome During Trofinetide TreatmentUniversity of Minnesota
- ENROLLING BY INVITATIONNANCT06739434GCB-002 in Treatment of Patients With Rett SyndromeGenecombio Ltd.
- ACTIVE NOT RECRUITINGNANCT07418905Technology-supported Motor Rehabilitation for People With Rett SyndromeGeorgetown University
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06152237Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)Taysha Gene Therapies, Inc.